elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q34291281-2EB8A7A3-2C09-47AF-8984-DD3AF80C7143
Q34291281-2EB8A7A3-2C09-47AF-8984-DD3AF80C7143
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34291281-2EB8A7A3-2C09-47AF-8984-DD3AF80C7143
An open-label, single-arm, phase 2 study of single-agent carfilzomib in patients with relapsed and/or refractory multiple myeloma who have been previously treated with bortezomib.
P2093
Q34291281-2EB8A7A3-2C09-47AF-8984-DD3AF80C7143
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34291281-2EB8A7A3-2C09-47AF-8984-DD3AF80C7143
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7e881371b7d39a35e259a57eb7de8832c0e9cd01
P1545
3
http://www.w3.org/2001/XMLSchema#string
P2093
Sundar Jagannath
http://www.w3.org/2001/XMLSchema#string